Search results

Filters
Close
ADDED DATE
Added date
AUTHOR Please select
TOPICS Please select
WATCH / LISTEN / READ TIME
Claire Lew
Job title: ISCP Governor for Singapore & Senior Pharmacist
Ms Claire Lew is ISCP Governor for Singapore & Senior Pharmacist, Tan Tock Seng Hospital, SG. Ms Claire Lew is involved in the running of pharmacist-run cardiology clinics such as the Heart Failure Pharmacist Clinic, Post Percutaneous Intervention (PCI) Pharmacist Clinic, as well as the Anti-coagulation Services in Tan Tock Seng Hospital. ISCP Governors act as representatives for different… View more
Contemporary Techniques for Coronary Chronic Total Occlusions Revascularisation: Sharing Experience in a Global World
Author(s): Heinz Joachim Büttner , Masahisa Yamane , Nicolaus Reifart , et al Added: 3 years ago
Introduction and Objectives A symposium, chaired by Dr Heinz Joachim Büttner of Freiburg-Bad Krozingen (Germany) and Dr Masahisa Yamane of St Luke’s International Hospital (Tokyo, Japan) took place at EuroPCR, Paris on May 23rd, 2014. Its objectives were as follows: to learn how to improve the success of percutaneous intervention (PCI) in chronic total occlusion (CTO) by matching techniques to… View more

MI/ACS

Intervention
Edoxaban: ENGAGEing in Individualisation of DOACs
Author(s): Doreen Su-Yin Tan , Gheorghe-Andrei Dan , Oskars Kalējs , et al Start date: Aug 10, 2022

Anticoagulation

Standards & Guidelines
PCI During Cardiac Arrest and Ongoing Chest Compressions
Author(s): Göran K Olivecrona , Marko Noc Added: 3 years ago
Although approximately 2,000,000 patients undergo PCI yearly worldwide, only a very small minority will suffer a protracted cardiac arrest episode during the procedure that results in death.1 Cardiac arrest itself in the catheterisation laboratory (cath lab) is not an uncommon event, but is usually rapidly resolved with cardiopulmonary resuscitation (CPR) and DC conversions in cases of… View more

MI/ACS

Intervention
Author(s): Jamie Layland Added: 3 years ago
Introduction Ischaemic heart disease, a major public health issue, is responsible for one in every six deaths and an estimated 1,065,000 will have an acute coronary syndrome (ACS) annually.1 ACS is an umbrella term that comprises unstable angina, non-ST segment elevation myocardial infarction (NSTEMI) and ST-segment elevation myocardial infarction (STEMI).2 NSTEMI is the commonest form of acute… View more

Imaging & Diagnostics

MI/ACS
Rotatripsy in Left Main Disease
Author(s): Dinakar Bootla , Pruthvi C Revaiah , Navjyot Kaur , et al Added: 1 year ago

Prevention & Chronic Conditions

MI/ACS
The Impact of Calcium on Chronic Total Occlusion Management
Author(s): Claudia Cosgrove , Kalaivani Mahadevan , James Spratt , et al Added: 2 years ago

Imaging & Diagnostics

Intervention
Author(s): Gerald S Werner Added: 3 years ago
Introduction A chronic total occlusion (CTO) is defied as a 100 % occlusion in a coronary artery with Thrombolysis In Myocardial Infarction flw 0 (no antegrade flw beyond point of occlusion) and occlusion duration of >3 months. CTOs are found about 20 % of patients with coronary artery disease1 and their presence often excludes patients from undergoing percutaneous coronary intervention (PCI)… View more

Imaging & Diagnostics

Intervention
AHA 2019: Colchicine in Percutaneous Coronary Intervention (PCI)
Author(s): Binita Shah Added: 4 years ago
Dr Binita Shah (NYU Langone Health, New York, NY, US) discusses Colchicine in Percutaneous Coronary Intervention (PCI). Questions: 1.What is colchicine and why study it in PCI? 2.What was the study design, patient population and primary and secondary outcomes? 3.What were your outcomes? 4.How do these compare to those in the COLCOT study? 5.How should your study be interpreted in clinical… View more

Intervention